Cargando…
Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design
Current antidepressant treatments are inadequate for many individuals, and when they are effective, they require several weeks of administration before a therapeutic effect can be observed. Improving the treatment of depression is challenging. Recently, the two-pore domain potassium channel TREK-1 h...
Autores principales: | Mazella, Jean, Pétrault, Olivier, Lucas, Guillaume, Deval, Emmanuel, Béraud-Dufour, Sophie, Gandin, Carine, El-Yacoubi, Malika, Widmann, Catherine, Guyon, Alice, Chevet, Eric, Taouji, Said, Conductier, Grégory, Corinus, Alain, Coppola, Thierry, Gobbi, Gabriella, Nahon, Jean-Louis, Heurteaux, Catherine, Borsotto, Marc |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854129/ https://www.ncbi.nlm.nih.gov/pubmed/20405001 http://dx.doi.org/10.1371/journal.pbio.1000355 |
Ejemplares similares
-
The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1
por: Mazella, Jean, et al.
Publicado: (2019) -
Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity
por: Djillani, Alaeddine, et al.
Publicado: (2017) -
Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin
por: Hivelin, Céline, et al.
Publicado: (2016) -
Editorial: Sortilin and Sortilin Partners in Physiology and Pathologies
por: Mazella, Jean, et al.
Publicado: (2019) -
Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the “spadin” Antidepressant
por: Vallée, Nicolas, et al.
Publicado: (2016)